Cargando…
Sedation with Sevoflurane versus Propofol in COVID-19 Patients with Acute Respiratory Distress Syndrome: Results from a Randomized Clinical Trial
Background: Acute respiratory distress syndrome (ARDS) related to COVID-19 (coronavirus disease 2019) led to intensive care units (ICUs) collapse. Amalgams of sedative agents (including volatile anesthetics) were used due to the clinical shortage of intravenous drugs (mainly propofol and midazolam)....
Autores principales: | Martínez-Castro, Sara, Monleón, Berta, Puig, Jaume, Ferrer Gomez, Carolina, Quesada, Marta, Pestaña, David, Balvis, Alberto, Maseda, Emilio, de la Rica, Alejandro Suárez, Feijoo, Ana Monero, Badenes, Rafael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305722/ https://www.ncbi.nlm.nih.gov/pubmed/37373914 http://dx.doi.org/10.3390/jpm13060925 |
Ejemplares similares
-
Modified sevoflurane-based sedation technique versus propofol sedation technique: A randomized-controlled study
por: Syaed El Ahl, Mohamed Ibrahim
Publicado: (2015) -
Inhalation sedation for postoperative patients in the intensive care unit: initial sevoflurane concentration and comparison of opioid use with propofol sedation
por: Jung, Seungho, et al.
Publicado: (2020) -
Precision Medicine in Sepsis and Septic Shock
por: Suarez-de-la-Rica, Alejandro, et al.
Publicado: (2022) -
The role of cefiderocol in clinical practice
por: Maseda, Emilio, et al.
Publicado: (2022) -
Controversies in the management of ESBL-producing Enterabacterales. Clinical Implications
por: Maseda, Emilio, et al.
Publicado: (2022)